The slow two-step binding kinetics of TZD ligands to HDAC4 is consistent with an induced fit binding mechanism, which prolongs the residence time and is an important key parameter for the selection and development of safer active substances with long-lasting biological effects, particularly in indication areas such as cancer or anti-infective applications. The gene discussed is HDAC4; the disease is cancer.